| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | Options Exercise | $334,357 | +4,087 | +5.05% | $81.81 | 85,012 | 19 Nov 2024 | Direct | |
| transaction | EOG | Common Stock | Disposed to Issuer | $-334,350 | -2,459 | -2.89% | $135.97 | 82,553 | 19 Nov 2024 | Direct | |
| transaction | EOG | Common Stock | Tax liability | $-87,157 | -641 | -0.78% | $135.97 | 81,912 | 19 Nov 2024 | Direct | |
| holding | EOG | Common Stock | 8,000 | 19 Nov 2024 | Family Trust (AD) | ||||||
| holding | EOG | Common Stock | 8,000 | 19 Nov 2024 | Family Trust (KD) | ||||||
| holding | EOG | Common Stock | 8,000 | 19 Nov 2024 | Family Trust (PD) | ||||||
| holding | EOG | Common Stock | 14,000 | 19 Nov 2024 | By Wife |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -4,087 | -100% | $0.000000 | 0 | 19 Nov 2024 | Common Stock | 4,087 | $81.81 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The SARs granted became exercisable in increments of 33.3%, 33.3%, and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted became fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock. |